المؤلفون: Tsao T; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; T. Tsao and L. Qiu contributed equally., Qiu L; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; T. Tsao and L. Qiu contributed equally., Bharti R; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Shemesh A; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy San Francisco, San Francisco, CA, USA., Hernandez AM; Parker Institute for Cancer Immunotherapy San Francisco, San Francisco, CA, USA.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Cleary SJ; Institute of Pharmaceutical Science, King's College London, London, UK., Greenland NY; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Santos J; Department of Surgery, University of California San Francisco - East Bay, Oakland, CA, USA., Shi R; Dren Bio, Foster City, CA, USA., Bai L; Dren Bio, Foster City, CA, USA., Richardson J; Dren Bio, Foster City, CA, USA., Dilley K; Dren Bio, Foster City, CA, USA., Will M; Dren Bio, Foster City, CA, USA., Tomasevic N; Dren Bio, Foster City, CA, USA., Sputova T; Dren Bio, Foster City, CA, USA., Salles A; Dren Bio, Foster City, CA, USA., Kang J; Dren Bio, Foster City, CA, USA., Zhang D; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Hays SR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Kukreja J; Department of Surgery, University of California San Francisco, San Francisco, CA, USA., Singer JP; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Lanier LL; Parker Institute for Cancer Immunotherapy San Francisco, San Francisco, CA, USA.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Looney MR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Greenland JR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Medical Service, Veterans Affairs Health Care System, San Francisco, CA, USA., Calabrese DR; Department of Medicine, University of California San Francisco, San Francisco, CA, USA daniel.calabrese@ucsf.edu.; Medical Service, Veterans Affairs Health Care System, San Francisco, CA, USA.

المصدر: The European respiratory journal [Eur Respir J] 2024 Sep 26; Vol. 64 (3). Date of Electronic Publication: 2024 Sep 26 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Reperfusion Injury*/immunology , Lung Transplantation* , Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism , NK Cell Lectin-Like Receptor Subfamily D*/metabolism , NK Cell Lectin-Like Receptor Subfamily D*/immunology , Antibodies, Monoclonal*/pharmacology , Mice, Inbred C57BL*, Animals ; Mice ; Humans ; Male ; Disease Models, Animal ; Lung/immunology ; Lung/pathology ; Bronchoalveolar Lavage Fluid/immunology ; Bronchoalveolar Lavage Fluid/cytology ; Female

المؤلفون: Unione L; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance, Derio, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., Jiménez-Barbero J; Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance, Derio, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.; Department of Organic & Inorganic Chemistry, Faculty of Science and Technology, University of the Basque Country, Leioa, Spain.; Centro de Investigacion Biomedica En Red de Enfermedades Respiratorias, Madrid, Spain.

المصدر: ELife [Elife] 2024 Sep 20; Vol. 13. Date of Electronic Publication: 2024 Sep 20.

نوع المنشور: Journal Article; Editorial

بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE

مواضيع طبية MeSH: Polysaccharides*/metabolism , Polysaccharides*/immunology , Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism, Humans ; Animals ; Antibodies/immunology ; Antibodies/metabolism

المؤلفون: Blanquart E; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Ekren R; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Rigaud B; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Joubert MV; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Baylot V; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Daunes H; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Cuisinier M; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Villard M; Centre International de Recherche en Infectiologie, Université Lyon, Université Claude Bernard Lyon 1 INSERM U1111, Centre National de la Recherche Scientifique, UMR5308, École normale supérieure de Lyon, Université Jean Monnet de Saint-Etienne, Lyon, France., Carrié N; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Mazzotti C; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Lucca LE; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Perrot A; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Corre J; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Walzer T; Centre International de Recherche en Infectiologie, Université Lyon, Université Claude Bernard Lyon 1 INSERM U1111, Centre National de la Recherche Scientifique, UMR5308, École normale supérieure de Lyon, Université Jean Monnet de Saint-Etienne, Lyon, France., Avet-Loiseau H; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Axisa PP; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Martinet L; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France.; Centre International de Recherche en Infectiologie, Université Lyon, Université Claude Bernard Lyon 1 INSERM U1111, Centre National de la Recherche Scientifique, UMR5308, École normale supérieure de Lyon, Université Jean Monnet de Saint-Etienne, Lyon, France.

المصدر: Blood [Blood] 2024 Sep 19; Vol. 144 (12), pp. 1271-1283.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/immunology , Multiple Myeloma*/pathology , Multiple Myeloma*/therapy , Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism , Killer Cells, Natural*/pathology , Cell Adhesion*, Humans ; Prognosis ; Female ; Male ; Cytotoxicity, Immunologic ; Antigens, Differentiation, T-Lymphocyte/metabolism ; Middle Aged ; Aged ; Retrospective Studies ; Lymphocyte Function-Associated Antigen-1/metabolism ; Receptors, IgG ; GPI-Linked Proteins

المؤلفون: Wessel RE; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Ageeb N; Department of Biology, University of Virginia, Charlottesville, Virginia, USA., Obeid JM; Department of Thoracic Surgery, Temple University Hospital, Philadelphia, Pennsylvania, USA., Mauldin IS; Department of Surgery, University of Virginia, Charlottesville, Virginia, USA., Goundry KA; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Hanson GF; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Hossain M; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA., Lehman C; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA., Gentzler RD; Department of Medicine, Hematology and Oncology, University of Virginia, Charlottesville, Virginia, USA., Wages NA; Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA., Slingluff CL Jr; Department of Surgery, University of Virginia, Charlottesville, Virginia, USA., Bullock TNJ; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA.; Department of Pathology, University of Virginia, Charlottesville, Virginia, USA., Dolatshahi S; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA sdolatshahi@virginia.edu.; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA., Brown MG; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA.; Department of Medicine, Nephrology Division, University of Virginia, Charlottesville, Virginia, USA.; Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.; Department of Microbiology, Immunology and Cancer Biology, Univesity of Virginia, School of Medicine, Charlottesville, Virginia, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Sep 18; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/immunology , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/pathology , CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/metabolism , Lung Neoplasms*/immunology , Lung Neoplasms*/mortality , Lung Neoplasms*/pathology , Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism , Histocompatibility Antigens Class I*/metabolism , Histocompatibility Antigens Class I*/immunology, Humans ; Male ; Female ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism

المؤلفون: Sedloev D; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Chen Q; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Unglaub JM; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Schanda N; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Hao Y; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Besiridou E; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Neuber B; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Schmitt A; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Raffel S; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Liu Y; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Janssen M; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Müller-Tidow C; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Schmitt M; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany., Sauer T; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, 69120, Heidelberg, Germany. tim.sauer@med.uni-heidelberg.de.

المصدر: Journal of hematology & oncology [J Hematol Oncol] 2024 Sep 16; Vol. 17 (1), pp. 85. Date of Electronic Publication: 2024 Sep 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Killer Cells, Natural*/immunology , Killer Cells, Natural*/drug effects , Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/immunology , Leukemia, Myeloid, Acute*/drug therapy , Proteasome Inhibitors*/pharmacology , Proteasome Inhibitors*/therapeutic use , Receptors, Chimeric Antigen*/immunology , Bortezomib*/pharmacology , Bortezomib*/therapeutic use, Humans ; Animals ; Mice ; Cell Line, Tumor ; Oligopeptides/pharmacology ; Oligopeptides/therapeutic use ; Immunotherapy, Adoptive/methods ; Xenograft Model Antitumor Assays ; Mice, Inbred NOD ; Mice, SCID ; Female

المؤلفون: Chen AP; Cytovia Therapeutics, Inc., Natick, MA, USA. Electronic address: anping.chen@cytoviatx.com., Gao P; Cytovia Therapeutics, Inc., Natick, MA, USA., Lin L; Cytovia Therapeutics, Inc., Natick, MA, USA., Ashok P; Cytovia Therapeutics, Inc., Natick, MA, USA., He H; Cytovia Therapeutics, Inc., Natick, MA, USA., Ma C; Cytovia Therapeutics, Inc., Natick, MA, USA., Zou DL; Cytovia Therapeutics, Inc., Natick, MA, USA., Allain V; Gladstone-University of California, San Francisco Institute of Genomic Immunology, San Francisco, CA, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Université Paris Cité, INSERM UMR976, Hôpital Saint-Louis, Paris, France., Boyne A; Cellectis Inc, New York, NY, USA., Juillerat A; Cellectis Inc, New York, NY, USA., Duchateau P; Cellectis, Paris, France., Rath A; Cytovia Therapeutics, Inc., Aventura, FL, USA., Teper D; Cytovia Therapeutics, Inc., Aventura, FL, USA., Arulanandam A; Cytovia Therapeutics, Inc., Natick, MA, USA., Chang HM; Cytovia Therapeutics, Inc., Natick, MA, USA., Eyquem J; Gladstone-University of California, San Francisco Institute of Genomic Immunology, San Francisco, CA, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Li W; Cytovia Therapeutics, Inc., Natick, MA, USA. Electronic address: wei.li@cytoviatx.com.

المصدر: Cell reports methods [Cell Rep Methods] 2024 Sep 16; Vol. 4 (9), pp. 100857. Date of Electronic Publication: 2024 Sep 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918227360606676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2667-2375 (Electronic) Linking ISSN: 26672375 NLM ISO Abbreviation: Cell Rep Methods Subsets: MEDLINE

مواضيع طبية MeSH: Induced Pluripotent Stem Cells*/metabolism , Induced Pluripotent Stem Cells*/cytology , Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism , Interleukin-15*/genetics , Interleukin-15*/metabolism , Receptor, Transforming Growth Factor-beta Type II*/genetics , Receptor, Transforming Growth Factor-beta Type II*/metabolism, Humans ; Cell Differentiation ; Transcription Activator-Like Effector Nucleases/metabolism ; Transcription Activator-Like Effector Nucleases/genetics ; Gene Editing/methods

المؤلفون: Selim MA; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Suef RA; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Saied E; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Abdel-Maksoud MA; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia., Almutairi SM; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia., Aufy M; Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria., Mousa AA; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt., Mansour MTM; Virology and Immunology Department, National Cancer Institute, Cairo University and Childern's Cancer Hospital, Cairo, Egypt., Farag MMS; Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.; Biomedical Research Department, Armed Forces College of Medicine (AFCM), Cairo, Egypt.; The Regional Centre for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt.

المصدر: Frontiers in immunology [Front Immunol] 2024 Sep 12; Vol. 15, pp. 1427519. Date of Electronic Publication: 2024 Sep 12 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism , Hepatitis B, Chronic*/immunology , Hepatitis B, Chronic*/virology , Hepatitis B virus*/immunology, Humans ; Adult ; Male ; Female ; Immunologic Surveillance ; Phenotype ; Middle Aged ; Cytokines/metabolism ; Cytokines/immunology ; Hep G2 Cells ; NK Cell Lectin-Like Receptor Subfamily K/metabolism ; Cytotoxicity, Immunologic ; Hepatitis B Surface Antigens/immunology ; Hepatitis B Surface Antigens/blood ; NK Cell Lectin-Like Receptor Subfamily D/immunology ; NK Cell Lectin-Like Receptor Subfamily D/metabolism ; Natural Cytotoxicity Triggering Receptor 1/metabolism

المؤلفون: Kumar B; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Singh A; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Basar R; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Uprety N; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Li Y; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Fan H; Department of Neurology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA., Cortes AKN; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kaplan M; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Acharya S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shaim H; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Xu AC; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wu M; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ensley E; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Fang D; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Banerjee PP; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Garcia LM; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Tiberti S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lin P; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rafei H; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Munir MN; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Moore M; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shanley M; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mendt M; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kerbauy LN; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Stem Cell Transplantation and Hemotherapy/Cellular Therapy, Hospital Israelita Albert Einstein, Sao Paulo 05652-900, Brazil., Liu B; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Biederstädt A; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gokdemir E; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ghosh S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kundu K; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Reyes-Silva F; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jiang XR; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wan X; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gilbert AL; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dede M; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Mohanty V; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dou J; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang P; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Liu E; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Muniz-Feliciano L; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Deyter GM; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Jain AK; Department of Epigenetics and Molecular Carcinogenesis, Center for Cancer Epigenetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rodriguez-Sevilla JJ; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Colla S; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Chen K; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Abbas HA; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rai K; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; MD Anderson Cancer Center Epigenetics Therapy Initiative, Houston, TX 77030, USA., Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Daher M; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

المصدر: Science translational medicine [Sci Transl Med] 2024 Sep 11; Vol. 16 (764), pp. eadp0004. Date of Electronic Publication: 2024 Sep 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/immunology , Epigenesis, Genetic* , Basic-Leucine Zipper Transcription Factors*/metabolism , Basic-Leucine Zipper Transcription Factors*/genetics , Killer Cells, Natural*/metabolism , Killer Cells, Natural*/immunology, Humans ; Animals ; Transforming Growth Factor beta/metabolism ; Signal Transduction ; Mice ; Cellular Reprogramming ; Smad3 Protein/metabolism ; Smad2 Protein/metabolism

المؤلفون: Guo Q; Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China., Yang A; Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China., Zhao R; Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China., Zhao H; Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China., Mu Y; Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China., Zhang J; Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China., Han Q; Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China. Electronic address: hanqiuju@sdu.edu.cn., Su Y; Department of Emergency Surgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China. Electronic address: wdsyh2003@126.com.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Sep 10; Vol. 138, pp. 112586. Date of Electronic Publication: 2024 Jul 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Nimodipine*/pharmacology , Nimodipine*/therapeutic use , Thioacetamide* , Hepatic Stellate Cells*/drug effects , Hepatic Stellate Cells*/immunology , Liver Cirrhosis*/drug therapy , Liver Cirrhosis*/chemically induced , Liver Cirrhosis*/pathology , Liver Cirrhosis*/immunology , Liver*/drug effects , Liver*/pathology , Liver*/immunology , Killer Cells, Natural*/drug effects , Killer Cells, Natural*/immunology , Mice, Inbred C57BL*, Animals ; Mice ; Male ; Calcium Channel Blockers/pharmacology ; Calcium Channel Blockers/therapeutic use ; Apoptosis/drug effects ; Humans ; Disease Models, Animal ; Cell Line ; Cellular Microenvironment/drug effects ; Myeloid-Derived Suppressor Cells/drug effects ; Myeloid-Derived Suppressor Cells/immunology

المؤلفون: Mohseni R; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Mahdavi Sharif P; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Behfar M; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Shojaei S; National Institute of Genetic Engineering and Biotechnology, Tehran, Iran., Shoae-Hassani A; Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran., Jafari L; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Khosravi A; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Nikfetrat Z; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran. aahamidieh@tums.ac.ir.

المصدر: Scientific reports [Sci Rep] 2024 Sep 09; Vol. 14 (1), pp. 20971. Date of Electronic Publication: 2024 Sep 09.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Neuroblastoma*/therapy , Neuroblastoma*/immunology , Neuroblastoma*/pathology , Killer Cells, Natural*/immunology , Killer Cells, Natural*/transplantation , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Transplantation, Autologous* , Neoplasm Recurrence, Local*/therapy, Humans ; Female ; Male ; Child, Preschool ; Child ; Treatment Outcome ; Transplantation, Homologous